GLPwatch
Byetta vs Ozempic
Drug comparison
Last updated 2026-05-28 15:46 UTCByetta (exenatide by AstraZeneca) and Ozempic (semaglutide by Novo Nordisk) are both injectable medications for type 2 diabetes, given under the skin. Ozempic is also approved to lower cardiovascular risk and help with chronic kidney disease, while Byetta is only for diabetes. Both require shots, but they use different active ingredients.
AI summary of the sources below.
| Byetta | Ozempic | |
|---|---|---|
| Active ingredient | exenatide | semaglutide |
| Manufacturer | astrazeneca | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes, cardiovascular risk reduction, chronic kidney disease |
| Label updated | 2025-09-02 | 2026-01-30 |